Clinical Trial: Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: SARS-CoV-2
Study Type: OBSERVATIONAL
Official Title: COMIRNATY Intramuscular Injection for 6 Months to 4 Years Old (Monovalent: Omicron XBB.1.5) Special Investigation for Booster Immunization in Children Aged 6 Months to 4 Years
Brief Summary:
The purpose of this post-marketing study is to assess the safety of Comirnaty monovalent XBB.1.5.for booster vaccination children ages 6 months though 4 years under actual use medical practice.
Read more